Skip to content
Research/Stem Cell Therapy/Human Mesenchymal Stem Cells

Human Mesenchymal Stem Cells

Human Mesenchymal Stem Cells (hMSCs) are multipotent stromal cells that can differentiate into a variety of cell types, including bone, cartilage, and fat cells. They are primarily used in regenerative medicine due to their ability to repair and regenerate damaged tissues, making them significant for longevity and health optimization. Their immunomodulatory properties also contribute to their potential in treating inflammatory and autoimmune conditions.

Intelligence Profile

Science

Human Mesenchymal Stem Cells (hMSCs) are multipotent stromal cells that can differentiate into various cell types, playing a role in tissue repair and immune modulation. Here's a look at their molecular and physiological actions based on available evidence:

  1. Tissue Regeneration and Repair:

    • hMSCs contribute to tissue repair by differentiating into specialized cells like osteoblasts, chondrocytes, and adipocytes. Evidence points to their role in promoting cartilage repair in animal models, suggesting potential for treating joint disorders (PMID: 42551700).

  2. Immune Modulation:

    • hMSCs secrete factors that modulate the immune response, potentially reducing inflammation. They are involved in regulating macrophage activity, which is crucial in controlling inflammatory conditions. For example, their effect in post-COVID-19 chronic cough indicates a role in reducing excessive immune reactions (PMID: 42553659).

  3. Angiogenesis and Blood Flow:

    • They can enhance angiogenesis, the formation of new blood vessels, which is crucial for tissue healing and regeneration. This process helps restore redox homeostasis and supports diabetic bone regeneration, emphasizing their role in osteogenic-angiogenic coupling (PMID: 42553951).

  4. Anti-Fibrotic Effects:

    • In pulmonary fibrosis models, hMSCs have been shown to aid in collagen degradation through the action of matrix metalloproteinases, thus reducing fibrotic tissue formation (PMID: 42552946).

  5. Exosome Secretion:

    • hMSCs produce extracellular vesicles or exosomes that carry bioactive molecules to target cells, influencing processes such as cell proliferation and injury repair. Their exosomes have been studied for therapeutic strategies in conditions like osteonecrosis (PMID: 42550377).

Clinical trials investigate their potential across various conditions, including liver cirrhosis (NCT03945487), cerebral hemorrhage (NCT02283879), and osteoarthritis (NCT06082440), reflecting their versatile therapeutic potential.

Disclaimer: The information above is for educational purposes and not a substitute for professional medical advice. Always consult healthcare professionals for medical concerns.